Latest News
Select the category
Scancell Preliminary Results for the Year Ended 30 April 2024
Scancell signs strategic partnership with PharmaJet for use of the Stratis® IM Needle-free delivery System in the development of SCIB1/iSCIB1+ cancer vaccine for Advanced Melanoma
Scancell Appoints Dr Nermeen Varawalla as Chief Medical Officer
Scancell Provides Update from iSCIB1+ Clinical Advisory Meeting to Strengthen Plans for Phase 2/3 Registration Clinical Trial
Appointment of Dr Florian Reinaud to Scancell Board of Directors
Scancell extends Convertible Loan Note redemption dates by a further two years
No results found.
Regulatory News Archive
JOIN OUR MAILING LIST
Sign up for news updates to stay up to date with Scancell.